CD4 and acute respiratory distress syndrome: Equivalent research has revealed a notable decline in CD4+, CD8+, and B lymphocyte counts, activation of Th1 and Th2 pathways, cytotoxicity, apoptosis, and endothelial dysfunction in ARDS patients.